AINOS INC (AIMD)
NASDAQInformation TechnologyBiotechnologySnapshot 2026-09-04
NASDAQInformation TechnologyBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · AIMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
AIMD — legal / regulatory event — Changes in Registrant’s Certifying Accountant
Dated 2026-07-10
Changes in Registrant’s Certifying Accountant. Following the expiration of the engagement with YCM CPA INC. (“YCM”), the Company’s independent registered public accounting firm, on July 9, 2026, the Company dismissed YCM as the Company’s independent registered public accounting firm. On the same day, the audit committee of the board of directors of the Company (the “Audit Committee”) engaged DLEE Accountancy, Inc. (“ DLEE ”) as the Company’s new independent registered public accounting firm,…
Why it matters: More data could improve AI Nose's skills and help it compete better.
Supportive ifNew data sets or partnerships are announced to boost Smell ID skills.
Worry ifNo updates or problems with expanding the data sets.
Why it matters: The credit facility's terms will change how flexible the company is with its money.
Worry ifThe company shares news of good terms. They also report successful use of the credit facility.
Less concerning ifThe company shows bad terms or cannot use the credit facility.
Why it matters: A new auditor can change how financials are reported. This affects trust in results.
Worry ifThe next financial report shows big changes or problems in accounting.
Less concerning ifThe financial report is similar to past reports. There are no major changes.
Why it matters: Revenue growth would signal that commercialization efforts are paying off. It is crucial for investor confidence.
Supportive ifQ3 2026 revenue exceeds $200,000, showing improvement from Q2.
Worry ifQ3 2026 revenue stays under $200,000. This shows ongoing problems.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$253 on $10,000 · ±2.5% | How much price usually moves either way. |
| Bad day | $961 loss on $10,000 · 9.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,965 loss on $10,000 · 69.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Earnings results will show if the company is getting better or still struggling.
Watch forEarnings report shows a profit or revenue growth compared to the previous quarter.
Also watch forEarnings report shows a loss or declining revenue compared to the previous quarter.
Why it matters: New partnerships could help Ainos reach more customers. This is important for its growth.
Supportive ifAinos plans to announce at least two new partnerships in the next quarter.
Worry ifNo new collaborations are reported in the next quarter.
Why it matters: Changes in auditors can change how much people trust financial reports.
Worry ifThe new auditor had a smooth start and received good feedback on reports.
Less concerning ifThere are problems or delays in reports after the auditor change.
Why it matters: Faster revenue growth in the Information Technology sector may help Ainos. This can make investors feel better.
Supportive ifSector revenue growth speeds up to more than 5% each year.
Worry ifSector revenue growth stays below 4% year over year.
Why it matters: A new accounting firm can change how much investors trust the company. It can also affect the quality of financial reports.
Worry ifDLEE Accountancy, Inc. provides a clean audit report for the next fiscal year.
Less concerning ifDLEE raises concerns about the financial statements. It may give a qualified opinion.
Why it matters: If revenue keeps falling, it shows problems with selling AI Nose.
Worry ifQ3 revenue falls below $152K, continuing the trend from Q2.
Less concerning ifQ3 revenue stabilizes or grows above $152K.
Why it matters: A smooth change to a new auditor may show stability; problems could cause worry.
Watch forNo issues reported with the new auditor, DLEE Accountancy, Inc.
Also watch forIssues with the new auditor or delays in reporting finances.
Why it matters: More use in healthcare shows Ainos is making progress with its AI Nose platform.
Supportive ifAinos announces new AI Nose deployments in at least two healthcare facilities.
Worry ifNo new healthcare deployments are reported in the next quarter.
Why it matters: This growth shows Ainos is doing well and that people want the AI Nose platform.
Supportive ifReported revenue from AI Nose exceeds $200K in Q3 2026.
Worry ifRevenue remains below $200K in Q3 2026.
Why it matters: A bigger dataset would improve the AI Nose's skills and help it in the market.
Supportive ifSmell ID dataset records grow by at least 100 million in the next quarter.
Worry ifDataset records do not increase or decline in the next quarter.
Why it matters: Higher costs might show problems in keeping expenses down while trying to grow.
Worry ifOperating costs were over $4 million in Q3 2026.
Less concerning ifOperating costs stayed below $4 million in Q3 2026.